Network origin in Bhupinder Singh first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Renibus Therapeutics, Inc.
 Renibus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Renibus Therapeutics, Inc. engages in manufacture of pharmaceutical products. The company was founded by Donald Jeffrey Keyser and Alvaro F. Guillem in 2015 and is headquartered in Southlake, TX.
4
| Holding Company | Pharmaceuticals: Major | 4 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Bhupinder Singh via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal | |
| IBM | Packaged Software | Corporate Officer/Principal | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Encysive Pharmaceuticals, Inc.
 Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | Pharmaceuticals: Major | Compliance Officer | |
| VERNALIS | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| GENVEC INC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| SANOFI | Pharmaceuticals: Major | Corporate Officer/Principal | |
Alba Therapeutics Corp.
 Alba Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Alba Therapeutics Corporation is a privately held, clinical-stage biopharmaceutical Company focused on the discovery, development and commercialization of pharmaceutical products to treat autoimmune and inflammatory diseases and is based in Baltimore, Maryland. Genetics, environment, aberrant immune response, and barrier dysfunction are all required for autoimmunity. Alba's technology platform is based on modifying disease state epithelial permeability using compounds which impact the regulation of tight junctions in cell barriers throughout the body with potential applications in celiac disease, Crohn's disease, asthma/COPD and acute lung injury. As a development stage company Alba maximizes value creation by leveraging its human capital, partnerships and technology. Since the Company's formation in 2004, the company has entered human clinical trials with its lead product, received Fast Track designation from the FDA (in Celiac Disease), successfully completed three Phase I clinical trials and completed its first Phase II study. Along with $30m raised in its Series A financing, equity and non-equity capital, such as SBIR and ATP grants and venture debt, are being used to develop products, enhance its powerful IP position and build the Company's infrastructure and core competencies | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
ZP Opco, Inc.
 ZP Opco, Inc. Pharmaceuticals: MajorHealth Technology ZP Opco, Inc. operates as a biopharmaceutical company that develops transdermal delivery technology for therapeutic indications. The company was founded by Peter E. Daddona and Frank D. Stonebanks in 2006 and is headquartered in Fremont, CA. | Pharmaceuticals: Major | Chief Executive Officer | |
Cynvec LLC
 Cynvec LLC Pharmaceuticals: MajorHealth Technology Cynvec LLC develops oncolytic therapeutics for the treatment of cancer. It offers cancer treatment platform to activate the body’s own immune system to safely attack tumors and prevent or slow cancer recurrence. The firm develops CYN-101, a bioengineered Sindbis viral vector vaccine expressing the NY-ESO-1 tumor associated antigen for the treatment of late-stage ovarian cancer; and an immunotherapeutic vaccine for multiple possible cancer targets. The company was founded in 2004 and is headquartered in New York, NY. | Pharmaceuticals: Major | Chief Executive Officer | |
| ZS PHARMA INC | Pharmaceuticals: Major | Founder Chief Tech/Sci/R&D Officer | |
Lumira Capital Investment Management, Inc.
 Lumira Capital Investment Management, Inc. Investment ManagersFinance Lumira Capital Investment Management is a Venture Capital firm, a subsidiary of Nordion (Canada),Inc. founded in 1989 by Tony Pullen. The firm is headquartered in Toronto. | Investment Managers | Private Equity Investor | |
| Dartmouth College | College/University | Undergraduate Degree | |
| Creighton University | College/University | Graduate Degree | |
| St. Joseph's University | College/University | Masters Business Admin | |
| The University of Texas at Dallas | College/University | Doctorate Degree | |
| University of Victoria | College/University | Undergraduate Degree | |
| University of Copenhagen | College/University | Doctorate Degree | |
| Adams Laboratories, Inc. | General Counsel | ||
| Novo-Nordisk Biochem, Inc. | Chief Tech/Sci/R&D Officer | ||
| University of Missouri-Kansas City | College/University | Graduate Degree | |
CSL Capital Management LLC
 CSL Capital Management LLC Investment ManagersFinance CSL Capital Management LLC (CSL Capital) is a private equity firm founded by Charles Leykum in 2008. The firm is headquartered in Houston, Texas. | Investment Managers | Director/Board Member | |
Ontario Institute for Cancer Research
 Ontario Institute for Cancer Research Hospital/Nursing ManagementHealth Services Ontario Institute for Cancer Research provides research on the prevention, early detection, diagnosis, and treatment of cancer. It offers Innovation programs, like cancer stem cell, innovation in target validation, and smarter imaging, Technology programs, like drug discovery, genome technologies, informatics and bio-computing, imaging translation, and tranformative pathology, and Translation programs. The company was founded by Calvin R. Stiller in December 2005 and is headquartered in Toronto, Canada. | Hospital/Nursing Management | Corporate Officer/Principal | |
| Medeva Americas, Inc. | General Counsel | ||
| Nabi Pharmaceuticals | Chief Tech/Sci/R&D Officer | ||
NovaQuest Capital Management LLC
 NovaQuest Capital Management LLC Investment ManagersFinance NovaQuest Capital Management LLC (NovaQuest Capital Management) is a private equity firm founded in 2010 by John Layton Bradley and Jonathan Edward Tunnicliffe. The firm is headquartered in Raleigh, North Carolina. | Investment Managers | Consultant / Advisor | |
| ALLAKOS INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Rasmussen Biotech & Pharma Consulting LLC | Chief Executive Officer | ||
Triphase Accelerator Corp.
 Triphase Accelerator Corp. BiotechnologyHealth Technology Triphase Accelerator Corp. develops oncology drug therapeutics. It engages in accelerating oncology products from pre-investigational new drug (pre-IND) to Phase I/Phase II POC. The firm?s product includes Marizomib which is used in cancer treatment. The company is headquartered in Toronto, Canada. | Biotechnology | Founder | |
| LANTERN PHARMA INC. | Pharmaceuticals: Major | Chairman | |
Wavemaker Three-Sixty Health
 Wavemaker Three-Sixty Health Investment ManagersFinance Wavemaker Three-Sixty Health (Wavemaker 360) is a venture capital firm founded in 2018 by John G. Nackel. The firm is headquartered in Pasadena, California. | Investment Managers | Consultant / Advisor | |
Neoprogen, Inc.
 Neoprogen, Inc. BiotechnologyHealth Technology Neoprogen, Inc. engages in the development of cell-based therapy for people who experience a heart attack. The company was founded by Sunjay Kaushal, Rachana Mishra and Sudhish Sharma and is headquartered in Baltimore, MD. | Biotechnology | Director/Board Member | |
Teal Ventures Management LLC
 Teal Ventures Management LLC Investment ManagersFinance Teal Ventures Management LLC (Teal Ventures) is a venture capital firm founded by Nikolay Savchuk, Ron Demuth, and Eddie Rodriguez in 2018. The firm Headquartered in San Diego, California. | Investment Managers | Founder | |
| ZOSANO PHARMA CORPORATION | Pharmaceuticals: Major | Founder |
Statistics
International
| United States | 33 |
| Canada | 5 |
| France | 3 |
| United Kingdom | 2 |
| Denmark | 2 |
Sectoral
| Health Technology | 20 |
| Consumer Services | 8 |
| Finance | 6 |
| Health Services | 3 |
| Technology Services | 2 |
Operational
| Director/Board Member | 9 |
| Chief Tech/Sci/R&D Officer | 9 |
| Corporate Officer/Principal | 8 |
| Founder | 8 |
| General Counsel | 7 |
Most connected contacts
| Insiders | |
|---|---|
| Frank Stonebanks | 17 |
| Henrik Rasmussen | 14 |
| Donald Keyser | 13 |
| Carlos Guillem | 1 |
- Stock Market
- Insiders
- Bhupinder Singh
- Company connections
